The BCL6-IRF4-BLIMP1 transcription factor axis as a therapeutic target in T-cell lymphoma

by Gibson, Paul David
Published 2016

A randomized trial to assess the impact of an antithrombotic decision aid in patients with nonvalvular atrial fibrillation: the DAAFI trial protocol [ISRCTN14429643]

by Anderson David, Gibson Paul, Ghali William A, Straus Sharon E, Man-Son-Hing Malcolm, McAlister Finlay A, Cox Jafna, Fradette Miriam
Published 2004-05-01

Do children with central venous line (CVL) dysfunction have increased risk of symptomatic thromboembolism compared to those without CVL-dysfunction, while on cancer therapy?

by Halton Jacqueline, Nagel Kim, Brandão Leonardo R, Silva Mariana, Gibson Paul, Chan Anthony, Blyth Kay, Hicks Kim, Parmar Nagina, Paddock Leslie, Willing Stephanie, Thabane Lehana, Athale Uma
Published 2012-07-01

Cytochrome P450 1B1 (CYP1B1) is over-expressed in human colon adeno-carcinomas relative to normal colon: Implications for drug development.

by Gibson, Paul, Gill, Jason H., Khan, Parveen A., Seargent, Jill M., Martin, Sandie W., Batman, Philip A., Griffith, John, Bradley, C., Double, John A., Bibby, Michael C., Loadman, Paul M.
Published 2009